Drawing for IMPASS

USPTO serial 97714252

IMPASS

Reviewed by CopyMark Law Group

Reg. 7348734Status 700Registered
Filing date
Status date
Registration date
Apr 2, 2024
Examiner
DONINGER, CHRISTOPHER G
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with IMPASS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
010Embolic devices for creating vessel occlusionACTIVENov 16, 2023

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 1, 2025ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Apr 2, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Apr 2, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 29, 2024SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Feb 28, 2024CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Feb 28, 2024DOCKASSIGNED TO EXAMINER—
Feb 4, 2024SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Feb 4, 2024AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 15, 2024IUAFUSE AMENDMENT FILED—
Jan 15, 2024EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jan 9, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 5, 2024EX1GSOU EXTENSION 1 GRANTED—
Jan 5, 2024EXT1SOU EXTENSION 1 FILED—
Jan 5, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 19, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 24, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 24, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 4, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 15, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 15, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Sep 15, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 15, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 15, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 15, 2023DOCKASSIGNED TO EXAMINER—
Jan 9, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 15, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance